💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
GPT Healthcare Limited is an India-based company. The Company’s principal activities include the operation of multidisciplinary private hospitals and pharmacies. It has four multispecialty hospitals, two in Kolkata, Salt Lake, one in Agartala and one hospital in Howrah, West…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A high-quality, stagnant business, fairly priced.
GPT HEALTHCARE LIMITED is scored on the pharma / healthcare framework. It keeps a slim 8.8% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.92× reported profit. Free cash flow is worth about 2.9% of its market value.
Over the last 3 years revenue compounded at 9%/yr and profit at 3%/yr. Book value itself has compounded 18%/yr — the hallmark of a genuine compounder. Return on equity is an elite 28.5%. In the latest quarter profit fell 13% versus the prior quarter.
At 28× earnings, the stock sits at the 59th percentile of its own 2.7-year range — the middle of where it has historically traded. Today's price implies ~12%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 25.01 | 75.62 | better |
| P/B | 4.39 | 3.49 | worse |
| EV/EBITDA | 13.01 | 19.95 | better |
| ROE | 28.53 | — | — |
| ROCE | 23.48 | 10.81 | better |
| ROA | 15.01 | 3.84 | better |
| Quick Ratio | 1.14 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Apollo Hospitals | 52.0 | 11.4 | 21.1% |
| Max Healthcare | 65.9 | 8.0 | 12.2% |
| Manipal Health Enterprises | 93.9 | 5.2 | 10.6% |
Revenue has grown every year across all 4 financial years shown. 9% CAGR — growing but slowly. Growth is accelerating — latest year outpaced the prior year's rate.
Profit is on a 2-year growth streak. Revenue is outpacing profit (9% vs 3%) — costs are rising faster than the top line.
Operating margin has compressed from 15% to 11% — costs or competition are eating into profitability.
ROE at 16% — a respectable return on shareholder capital. Capital efficiency declining — ROE down 8pp.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play. 2% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 1.9× PAT — earnings are well-backed by cash; strong accrual quality. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue broadly flat QoQ — stable but not accelerating. Low quarterly variance (6% spread) — a predictable, non-seasonal revenue stream.
Profit fell 13% QoQ — one-quarter drops can be noise, but a pattern matters.
How today's P/E compares to the stock's own historical range. Dashed line = the 2.7y median.
Promoters hold 65.6% — heavily owner-operated with strong skin in the game.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.